Spots Global Cancer Trial Database for psma pet scan
Every month we try and update this database with for psma pet scan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | NCT05806515 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... | Biospecimen Col... Carboplatin Chest Radiograp... Computed Tomogr... Magnetic Resona... PSMA PET Scan Surgical Proced... | 18 Years - | SWOG Cancer Research Network | |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) | NCT06216249 | Prostate Carcin... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... PSMA PET Scan Questionnaire A... Single Photon E... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer | NCT06129851 | Stage IIC Prost... Stage III Prost... Stage IV Prosta... | Biospecimen Col... Bone Scan Brachytherapy Computed Tomogr... Dual X-ray Abso... External Beam R... Magnetic Resona... PSMA PET Scan Questionnaire A... Relugolix | 18 Years - | University of Kansas Medical Center | |
| Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer | NCT05109884 | Prostate Cancer | PSMA PET Scan FDHT PET Scan | 18 Years - 75 Years | Medical University of Vienna | |
| Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer | NCT05733351 | Castration-Sens... Metastatic Pros... Stage IVB Prost... | Abiraterone Biospecimen Col... Bone Scan Computed Tomogr... Docetaxel Enzalutamide FDG-Positron Em... Magnetic Resona... PSMA PET Scan Vudalimab | 18 Years - | Emory University | |
| Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer | NCT05109884 | Prostate Cancer | PSMA PET Scan FDHT PET Scan | 18 Years - 75 Years | Medical University of Vienna | |
| Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study | NCT05960578 | Castration-Resi... Prostate Adenoc... | Apalutamide Biopsy Biospecimen Col... Computed Tomogr... Golimumab Magnetic Resona... PSMA PET Scan | 18 Years - | University of Washington | |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) | NCT06216249 | Prostate Carcin... Stage IVB Prost... | Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... PSMA PET Scan Questionnaire A... Single Photon E... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study | NCT04175431 | Prostate Adenoc... | Positron Emissi... Lymphadenectomy Radiation Thera... Abiraterone Ace... Prednisone Computed Tomogr... Abiraterone PSMA PET Scan | 18 Years - | University of Washington | |
| Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer | NCT04895735 | Metastatic Sali... Recurrent Saliv... Stage IV Major ... Adenoid Cystic ... | Pembrolizumab Pemetrexed Diso... Biospecimen Col... Computed Tomogr... Positron Emissi... Magnetic Resona... PSMA PET Scan | 18 Years - | Mayo Clinic | |
| MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer | NCT05676463 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... | MRI-guided Inte... Antiandrogen Th... PSMA PET Scan Computed Tomogr... Magnetic Resona... Bone Scan Biospecimen Col... Quality-of-Life... | 18 Years - | Thomas Jefferson University | |
| Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer | NCT04895735 | Metastatic Sali... Recurrent Saliv... Stage IV Major ... Adenoid Cystic ... | Pembrolizumab Pemetrexed Diso... Biospecimen Col... Computed Tomogr... Positron Emissi... Magnetic Resona... PSMA PET Scan | 18 Years - | Mayo Clinic | |
| Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | NCT05806515 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... | Biospecimen Col... Carboplatin Chest Radiograp... Computed Tomogr... Magnetic Resona... PSMA PET Scan Surgical Proced... | 18 Years - | SWOG Cancer Research Network | |
| MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer | NCT05676463 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... | MRI-guided Inte... Antiandrogen Th... PSMA PET Scan Computed Tomogr... Magnetic Resona... Bone Scan Biospecimen Col... Quality-of-Life... | 18 Years - | Thomas Jefferson University | |
| MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer | NCT05438563 | Prostate Carcin... Stage I Prostat... Stage II Prosta... | MRI-Guided Tran... Quality-of-Life... Questionnaire A... Digital Rectal ... Cystoscopy Biopsy Bone Scan PSMA PET Scan Multiparametric... | 45 Years - 80 Years | Mayo Clinic |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
